Skip to content

Function Health has a 23andMe problem

0.5718
Chimera Difficulty Score
a synthesis of Flesch-Kincaid, Coleman-Liau, SMOG, and Dale-Chall readability metrics
By DEEKSHA HEGDE I had an itch to draw parallels between the two. The structural facts kept lining up in ways I couldn’t dismiss, and by the end, I stopped trying. Function’s product is an app: you pay $365 a year, go to a Quest Diagnostics location, get 160+ biomarkers tested twice a year, and receive clinician-written notes interpreting your results. The lab testing is fully outsourced. Function...
Function Health's strategy bears resemblance to 23andMe, another D2C health data company, but with higher stakes. Both companies aim to monetize health data through research partnerships and AI development, and neither are HIPAA-covered entities. However, Function Health has a recurring subscription model and real switching costs, unlike 23andMe, which had a one-time kit sale model that failed. Function Health's biomarker data is also more clinically sensitive and directly useful than 23andMe's ...